U.S. Stem Cell, Inc.
U.S. Stem Cell, Inc. (USRM) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 9 transactions totaling $54.0K, demonstrating a bullish sentiment with $54.0K in net insider flow. The most recent transaction on Apr 25, 2022 involved a transaction of 2,500,000 shares valued at $0.
USRM Insider Activity Summary
Who Is Buying USRM Stock?
No significant insider buying has been recorded for USRM in the recent period.
Who Is Selling USRM Stock?
No significant insider selling has been recorded for USRM in the recent period.
Is U.S. Stem Cell, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for USRM is bullish with an Insider Alignment Score of 100/100 and a net flow of $54.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
USRM Frequently Asked Questions
Understanding USRM Insider Activity
Insider trading at U.S. Stem Cell, Inc. (USRM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading USRM stock, having executed 9 transactions in the past 90 days. The most active insider is William P. Murphy Jr (Executive), who has made 3 transactions totaling $332.0K.
Related Tools
Track U.S. Stem Cell, Inc. Insider Activity
Get notified when executives and directors at USRM file new Form 4 transactions